Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions

Transfusion

Volumn 50, Issue 5, 2010, Pages 1096-1105

  Tanaka, Shigenori ^a   Hayashi, Tomoya ^a   Tani, Yoshihiko ^a   Hirayama, Fumiya ^a  

^a OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CELLULOSE; RANTES; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; PROTEIN SECRETION; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE STRUCTURE; THROMBOCYTE TRANSFUSION;

ADSORPTION; ANTIGENS, CD; BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; IMMUNOLOGIC FACTORS; L-LACTATE DEHYDROGENASE; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; PLATELET MEMBRANE GLYCOPROTEINS; PLATELET TRANSFUSION;

EID: 77951673629     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02547.x     Document Type: Article

References (72)

1. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009 49 : 440 52.
2. Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009 108 : 770 6.
3. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev 2006 20 : 139 59.
4. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993 33 : 195 9. (Pubitemid 23073640)
5. Muylle L, Wouters E, Peetermans ME. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996 36 : 886 90. (Pubitemid 26349904)
6. Heddle NM. Febrile nonhemolytic transfusion reactions to platelets. Curr Opin Hematol 1995 2 : 478 83.
7. Klüter H, Bubel S, Kirchner H, Wilhelm D. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999 39 : 1179 84.
8. Pruss A, Kalus U, Radtke H, Koscielny J, Baumann-Baretti B, Balzer D, Dörner T, Salama A, Kiesewetter H. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apher Sci 2004 30 : 41 6. (Pubitemid 38117293)
9. Tamagawa-Mineoka R, Katoh N, Kishimoto S. Platelets play important roles in the late phase of the immediate hypersensitivity reaction. J Allergy Clin Immunol 2009 123 : 581 7.
10. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004 44 : 16 24. (Pubitemid 38177131)
11. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004 44 : 1683 8. (Pubitemid 39644050)
12. Reil A, Keller-Stanislawski B, Günay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008 95 : 313 7.
13. Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007 47 : 545 50. (Pubitemid 46272505)
14. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003 43 : 641 5. (Pubitemid 36506361)
15. Sandler SG, Zantek ND. Review: IgA anaphylactic transfusion reactions. Part II. Clinical diagnosis and bedside management. Immunohematology 2004 20 : 234 8.
16. Gilstad CW. Anaphylactic transfusion reactions. Curr Opin Hematol 2003 10 : 419 23.
17. Nishiki S, Hino M, Kumura T, Hashimoto S, Ohta K, Yamane T, Takubo T, Tatsumi N, Kitagawa S, Kamitani T, Watanabe Y, Shimada E, Juji T, Iida S. Effectiveness of washed platelet concentrate and red cell transfusions for a patient with anhaptoglobinemia with antihaptoglobin antibody. Transfus Med 2002 12 : 71 3. (Pubitemid 34184949)
18. Heal JM, Cowles J, Masel D, Rowe JM, Blumberg N. Antibodies to plasma proteins: an association with platelet transfusion refractoriness. Br J Haematol 1992 80 : 83 90.
19. Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 2006 46 : 800 10.
20. Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007 47 : 126 32. (Pubitemid 46006320)
21. Davenport RD. An introduction to chemokines and their roles in transfusion medicine. Vox Sang 2009 96 : 183 98.
22. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 108 : 2455 62. (Pubitemid 44497533)
23. Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 2007 5 : 788 96. (Pubitemid 46563579)
24. Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001 98 : 1047 54.
25. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006 46 : 1813 21. (Pubitemid 44435735)
26. Cognasse F, Payrat JM, Corash L, Osselaer JC, Garraud O. Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand. Blood 2008 112 : 4779 80.
27. Pruss A, Kalus U, Radtke H, Koscielny J, Baumann-Baretti B, Balzer D, Dörner T, Salama A, Kiesewetter H. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apher Sci 2004 30 : 41 6. (Pubitemid 38117293)
28. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004 44 : 16 24. (Pubitemid 38177131)
29. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994 331 : 625 8. (Pubitemid 24276861)
30. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, Garraud O. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006 46 : 1184 9. (Pubitemid 44139493)
31. Cognasse F, Osselaer JC, Payrat JM, Chavarin P, Corash L, Garraud O. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion 2008 48 : 809 13. (Pubitemid 351614918)
32. Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 2006 46 : 800 10.
33. Kameyoshi Y, Dörschner A, Mallet AI, Christophers E, Schröder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992 176 : 587 92.
34. Thomas DA, Massagué J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 2005 8 : 369 80. (Pubitemid 41579832)
35. Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 2006 213 : 213 27. (Pubitemid 44401503)
36. Wakamoto S, Fujihara M, Kuzuma K, Sato S, Kato T, Naohara T, Kasai M, Sawada K, Kobayashi R, Kudoh T, Ikebuchi K, Azuma H, Ikeda H. Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003 43 : 1038 46. (Pubitemid 37022362)
37. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992 149 : 636 42.
38. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, Grant JA. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993 150 : 3442 8. (Pubitemid 23129724)
39. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992 176 : 1489 95.
40. Chakrabarti S, Varghese S, Vitseva O, Tanriverdi K, Freedman JE. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 2005 25 : 2428 34. (Pubitemid 41552666)
41. van Kooten C, Gaillard C, Galizzi JP, Hermann P, Fossiez F, Banchereau J, Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 1994 24 : 787 92. (Pubitemid 24093770)
42. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 1992 176 : 1543 50.
43. Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999 100 : 614 20. (Pubitemid 29379750)
44. Jin Y, Nonoyama S, Morio T, Imai K, Ochs HD, Mizutani S. Characterization of soluble CD40 ligand released from human activated platelets. J Med Dent Sci 2001 48 : 23 7. (Pubitemid 33735591)
45. Viallard JF, Solanilla A, Gauthier B, Contin C, Déchanet J, Grosset C, Moreau JF, Praloran V, Nurden P, Pellegrin JL, Nurden AT, Ripoche J. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 2002 99 : 2612 4. (Pubitemid 34525455)
46. André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002 106 : 896 9. (Pubitemid 34925319)
47. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998 391 : 591 4. (Pubitemid 28157601)
48. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001 357 : 2023 4. (Pubitemid 32592392)
49. Zhang Y, Cao HJ, Graf B, Meekins H, Smith TJ, Phipps RP. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J Immunol 1998 160 : 1053 7. (Pubitemid 28093397)
50. Blumberg N, Phipps RP, Kaufman J, Heal JM. The causes and treatment of reactions to platelet transfusions. Transfusion 2003 43 : 291 2.
51. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983 258 : 7155 60. (Pubitemid 13059967)
52. Wadhwa M, Seghatchian MJ, Lubenko A, Contreras M, Dilger P, Bird C, Thorpe R. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 1996 93 : 225 34. (Pubitemid 26130732)
53. Childs CB, Proper JA, Tucker RF, Moses HL. Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci U S A 1982 79 : 5312 6.
54. Kunz D, Luley C, Heim MU, Böck M. Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion 1998 38 : 156 9. (Pubitemid 28145081)
55. Rebibo D, Simonet M, Hauser L Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions Transfus Clin Biol 2008 15 : 289 93. French.
56. Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006 108 : 3210 5.
57. de Wildt-Eggen J, Gulliksson H. In vivo and in vitro comparison of platelets stored in either synthetic media or plasma. Vox Sang 2003 84 : 256 64. (Pubitemid 36702332)
58. Azuma H, Hirayama J, Akino M, Miura R, Kiyama Y, Imai K, Kasai M, Koizumi K, Kakinoki Y, Makiguchi Y, Kubo K, Atsuta Y, Fujihara M, Homma C, Yamamoto S, Kato T, Ikeda H. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion 2009 49 : 214 8.
59. O'Neil PF, Balkovic ES. Virus harvesting and affinity-based liquid chromatography. A method for virus concentration and purification. Biotechnology (N Y) 1993 11 : 173 8.
60. Macmaster R, Sedelnikova S, Baker PJ, Bolt EL, Lloyd RG, Rafferty JB. RusA Holliday junction resolvase: DNA complex structure - insights into selectivity and specificity. Nucleic Acids Res 2006 34 : 5577 84. (Pubitemid 44752514)
61. Yeomans-Reina H, Ruiz-Manriquez A, Wong BR, Mansir AT. Selectivity of IMAC columns in trypsin inhibitor purification. Biotechnol Prog 2001 17 : 729 33. (Pubitemid 32748064)
62. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion 1998 38 : 31 40. (Pubitemid 28090937)
63. Patscheke H, Dubler D, Deranleau D, Luscher EF. Optical shape change analysis in stirred and unstirred human platelet suspension. A comparison of aggregometric and stopped-flow turbidimetric measurements. Thromb Res 1984 33 : 341 53. (Pubitemid 14182592)
64. Shanwell A, Falker C, Gulliksson H. Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, beta-thromboglobulin, platelet factor 4 and interleukin-7, during storage. Vox Sang 2003 85 : 206 12. (Pubitemid 37247804)
65. Fujihara M, Ikebuchi K, Wakamoto S, Sekiguchi S. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage. Transfusion 1999 39 : 498 505. (Pubitemid 29233274)
66. Geiger TL, Perrotta PL, Davenport R, Baril L, Snyder EL. Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters. Transfusion 1997 37 : 1156 62. (Pubitemid 28018689)
67. 51Cr recovery in vivo of preserved platelets. Transfusion 1974 14 : 331 7.
68. Kim BK, Baldini MG. The platelet response to hypotonic shock. Its values as an indicator of platelet viability after storage. Transfusion 1974 14 : 130 8.
69. Holme S, Sweeney JD, Sawyer S, Elfath MD. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997 37 : 12 7. (Pubitemid 27068934)
70. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005 3 : 9. (Pubitemid 41522127)
71. de Weck AL, Sanz ML, Gamboa PM, Aberer W, Bienvenu J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, Sainte-Laudy J. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008 146 : 177 89. (Pubitemid 351832459)
72. Matsuyama N, Hirayama F, Wakamoto S, Yasui K, Furuta RA, Kimura T, Taniue A, Fukumori Y, Fujihara M, Azuma H, Ikeda H, Tani Y, Shibata H. Application of the basophil activation test in the analysis of allergic transfusion reactions. Transf Med 2009 19 : 274 7.